Novavax, Inc.

Novavax, Inc.

Novavax, Inc. was founded in 1987 and is headquartered in Rockville, Maryland. Novavax, Inc., a clinical-stage biopharmaceutical company, focuses on developing vaccines using its virus-like particle platform technology for infectious diseases. It develops vaccines against the H5N1 and other subtypes of avian influenza with pandemic potential, human seasonal influenza, and Respiratory Syncytial Virus, as well as Varicella Zoster that causes shingles. The company has a joint venture with Cadila Pharmaceuticals Ltd. to develop and commercialize seasonal influenza virus-like-particle-based vaccine candidates and therapeutic vaccine candidates against cancer, as well as adjuvants, biogeneric products, and other diagnostic products for the territory of India. It also has a strategic collaboration Xcellerex Inc. for the production of 2009 H1N1 influenza vaccine.

Contact Details

Office Address

Novavax, Inc.
9920 Belward Campus Drive
Rockville, MD, USA 20850
Phone: (240) 268-2000
Fax: (240) 268-2100

Executives

Exec. Chairman

Mr. John Lambert

Chief Exec. Officer

Dr. Rahul Singhvi

Business Reviews for Novavax, Inc.

Related Companies